These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35363600)

  • 1. Lung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Trial.
    Parekh TM; Helgeson ES; Connett J; Voelker H; Ling SX; Lazarus SC; Bhatt SP; MacDonald DM; Mkorombindo T; Kunisaki KM; Fortis S; Kaminsky D; Dransfield MT
    Ann Am Thorac Soc; 2022 Oct; 19(10):1642-1649. PubMed ID: 35363600
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.
    Papi A; Hughes R; Del Olmo R; Agusti A; Chipps BE; Make B; Tomaszewski E; Peres Da Costa K; Srivastava D; Vestbo J; Janson C; Burgel PR; Price D
    Ther Adv Respir Dis; 2024; 18():17534666241254212. PubMed ID: 38841799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations.
    Hansen JE; Dilektasli AG; Porszasz J; Stringer WW; Pak Y; Rossiter HB; Casaburi R
    Ann Am Thorac Soc; 2019 Dec; 16(12):1504-1517. PubMed ID: 31404502
    [No Abstract]   [Full Text] [Related]  

  • 5. Metoprolol for the Prevention of Acute Exacerbations of COPD.
    Dransfield MT; Voelker H; Bhatt SP; Brenner K; Casaburi R; Come CE; Cooper JAD; Criner GJ; Curtis JL; Han MK; Hatipoğlu U; Helgeson ES; Jain VV; Kalhan R; Kaminsky D; Kaner R; Kunisaki KM; Lambert AA; Lammi MR; Lindberg S; Make BJ; Martinez FJ; McEvoy C; Panos RJ; Reed RM; Scanlon PD; Sciurba FC; Smith A; Sriram PS; Stringer WW; Weingarten JA; Wells JM; Westfall E; Lazarus SC; Connett JE;
    N Engl J Med; 2019 Dec; 381(24):2304-2314. PubMed ID: 31633896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ratio of FEV
    Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I
    Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in clinical significance of bronchodilator responses measured by forced expiratory volume in 1 second and forced vital capacity.
    Choi JY; Kim SK; Lee JH; Jung KS; Yoo KH; Hwang KE; Lee JD; Kim YI; Yoon HK; Um SJ
    PLoS One; 2023; 18(2):e0282256. PubMed ID: 36827406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
    Fortis S; Quibrera PM; Comellas AP; Bhatt SP; Tashkin DP; Hoffman EA; Criner GJ; Han MK; Barr RG; Arjomandi M; Dransfield MB; Peters SP; Dolezal BA; Kim V; Putcha N; Rennard SI; Paine R; Kanner RE; Curtis JL; Bowler RP; Martinez FJ; Hansel NN; Krishnan JA; Woodruff PG; Barjaktarevic IZ; Couper D; Anderson WH; Cooper CB;
    Chest; 2023 Mar; 163(3):502-514. PubMed ID: 36395858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis.
    Barjaktarevic IZ; Buhr RG; Wang X; Hu S; Couper D; Anderson W; Kanner RE; Paine Iii R; Bhatt SP; Bhakta NR; Arjomandi M; Kaner RJ; Pirozzi CS; Curtis JL; O'Neal WK; Woodruff PG; Han MK; Martinez FJ; Hansel N; Wells JM; Ortega VE; Hoffman EA; Doerschuk CM; Kim V; Dransfield MT; Drummond MB; Bowler R; Criner G; Christenson SA; Ronish B; Peters SP; Krishnan JA; Tashkin DP; Cooper CB;
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2927-2938. PubMed ID: 31908441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
    Keam SJ; Keating GM
    Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the Bronchodilator Test Defined by the Forced Vital Capacity in Chronic Obstructive Pulmonary Disease Phenotyping.
    Zhang X; Wu Z; Liu Y; Jiang S
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1199-1206. PubMed ID: 32547006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol.
    Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT
    BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD.
    Tashkin DP; Li N; Halpin D; Kleerup E; Decramer M; Celli B; Elashoff R
    Respir Med; 2013 Dec; 107(12):1904-11. PubMed ID: 23972968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study.
    Buhr RG; Barjaktarevic IZ; Quibrera PM; Bateman LA; Bleecker ER; Couper DJ; Curtis JL; Dolezal BA; Han MK; Hansel NN; Krishnan JA; Martinez FJ; McKleroy W; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Kanner RE; Cooper CB;
    Am J Respir Crit Care Med; 2022 Sep; 206(5):554-562. PubMed ID: 35549640
    [No Abstract]   [Full Text] [Related]  

  • 17. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
    Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebulization
    Lu R; Li Y; Hu C; Pan P; Zhao Q; He R
    Ther Adv Respir Dis; 2023; 17():17534666231214134. PubMed ID: 38073272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial.
    Watz H; Tetzlaff K; Magnussen H; Mueller A; Rodriguez-Roisin R; Wouters EFM; Vogelmeier C; Calverley PMA
    Respir Res; 2018 Dec; 19(1):251. PubMed ID: 30545350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study.
    Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC
    BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.